Starling Oncology Institute Inc (STLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,209 | -996 | -14,322 | -5,812 | -3,396 |
| Depreciation Amortization | 1,606 | 795 | 3,238 | N/A | N/A |
| Income taxes - deferred | 221 | 221 | -1,344 | N/A | N/A |
| Accounts receivable | -1,794 | -550 | -6,763 | N/A | N/A |
| Accounts payable and accrued liabilities | 951 | 474 | 3,758 | 1 | N/A |
| Other Working Capital | -4,887 | 402 | 992 | -8 | -149 |
| Other Operating Activity | -4,972 | 118 | 14,949 | 5,318 | 3,113 |
| Operating Cash Flow | $-6,666 | $464 | $508 | $-501 | $-432 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,026 | -619 | -1,194 | N/A | N/A |
| Net Acquisitions | -827 | -827 | -150 | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | -230,000 | -230,000 |
| Purchase Sale Intangibles | -200 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -200 | 0 | -7,500 | 0 | 0 |
| Investing Cash Flow | $-2,053 | $-1,446 | $-8,844 | $-230,000 | $-230,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 2,500 | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | 12,493 | N/A | 200 |
| Debt Repayment | -2,110 | -104 | -312 | N/A | -200 |
| Common Stock Issued | N/A | N/A | 50 | 225,875 | 235,600 |
| Other Financing Activity | 20,000 | 20,000 | -343 | 5,600 | -4,090 |
| Financing Cash Flow | $17,890 | $22,396 | $11,888 | $231,475 | $231,510 |
| Beginning Cash Position | 5,998 | 5,998 | 2,446 | 25 | 25 |
| End Cash Position | 15,169 | 27,412 | 5,998 | 999 | 1,103 |
| Net Cash Flow | $9,171 | $21,414 | $3,552 | $974 | $1,078 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,666 | 464 | 508 | -501 | -432 |
| Capital Expenditure | -1,026 | -619 | -1,194 | N/A | N/A |
| Free Cash Flow | -7,692 | -155 | -686 | -501 | -432 |